コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 PSC-derived lineages in disease modeling and regenerative medicine.
2 plinary studies, including organogenesis and regenerative medicine.
3 therapy and biomaterials for applications in regenerative medicine.
4 e major stem cells used for cell therapy and regenerative medicine.
5 for basic developmental biology research and regenerative medicine.
6 rstanding human disease, drug discovery, and regenerative medicine.
7 tion of other tissue-specific stem cells for regenerative medicine.
8 amental aspects of developmental biology and regenerative medicine.
9 ogels may find broad utility in the field of regenerative medicine.
10 c cells into neurons holds great promise for regenerative medicine.
11 ns for translational applications, including regenerative medicine.
12 (hiPSCs) have potential for personalized and regenerative medicine.
13 h a pluripotent state, has great promise for regenerative medicine.
14 to a cascade of technological innovations in regenerative medicine.
15 us stem cells represents an ultimate goal in regenerative medicine.
16 st valuable sources of somatic stem cells in regenerative medicine.
17 fields, from evo-devo to cancer research and regenerative medicine.
18 essment, may improve clinical application in regenerative medicine.
19 ensure hiPSC quality for drug discovery and regenerative medicine.
20 ardiac reprogramming holds great promise for regenerative medicine.
21 f great interest for biomedical research and regenerative medicine.
22 es to improve cell and tissue production for regenerative medicine.
23 the complex nature of congenital disease and regenerative medicine.
24 ntial impact of nanotechnology in MSC-driven regenerative medicine.
25 ed is also of great interest in the field of regenerative medicine.
26 gh-throughput drug screening devices, and in regenerative medicine.
27 ell heterogeneity, complicating their use in regenerative medicine.
28 l solution to overcome this key challenge in regenerative medicine.
29 e and suggest new therapeutic approaches for regenerative medicine.
30 tent stem (iPS) cells holds great promise in regenerative medicine.
31 cell types and thus have great potential for regenerative medicine.
32 e body makes them invaluable in the field of regenerative medicine.
33 been a long sought-after but elusive goal in regenerative medicine.
34 tages for their use in disease modelling and regenerative medicine.
35 become a promising tool for cell therapy in regenerative medicine.
36 ing SCNT in a variety of contexts, including regenerative medicine.
37 enefit from using this class of compounds in regenerative medicine.
38 ity in disease modeling, drug screening, and regenerative medicine.
39 tical insight into the unfolding frontier of regenerative medicine.
40 s the genetic state of cells used in cardiac regenerative medicine.
41 o features are therefore highly desirable in regenerative medicine.
42 nano-fibrous mats for tissue engineering and regenerative medicine.
43 ularly beneficial for future applications in regenerative medicine.
44 opportunities of magnetic nanoparticles for regenerative medicine.
45 of neuroscience, developmental biology, and regenerative medicine.
46 tem cells (iPSCs) holds enormous promise for regenerative medicine.
47 m cells, and we discuss the implications for regenerative medicine.
48 ction with the aim of inspiring their use in regenerative medicine.
49 mplex organ buds with broad applications for regenerative medicine.
50 as well as an emerging source of tissue for regenerative medicine.
51 the potential applications of these cells in regenerative medicine.
52 to approval of a new biological therapy for regenerative medicine.
53 yocardium with new tissue is a major goal of regenerative medicine.
54 PSCs) holds the potential for application in regenerative medicine.
55 may advance the understanding of periodontal regenerative medicine.
56 applications ranging from bioelectronics to regenerative medicine.
57 ially in the fields of stem cell biology and regenerative medicine.
58 studying cardiac biology, drug discovery and regenerative medicine.
59 pproaches to engineer cells for research and regenerative medicine.
60 regeneration is viewed as the holy grail of regenerative medicine.
61 tem cells (iPSCs) holds enormous promise for regenerative medicine.
62 Thus, our study advances the goals of liver regenerative medicine.
63 nds, and possibly of cell transplantation in regenerative medicine.
64 g the developmental course, and personalized regenerative medicine.
65 dding to the complexity of cell sourcing for regenerative medicine.
66 ally tensile properties, hinders progress in regenerative medicine.
67 clinical applications of MSCs in cancer and regenerative medicine.
68 ss in the field of developmental biology and regenerative medicine.
69 es remains a major challenge in the field of regenerative medicine.
70 may offer novel avenues for therapeutics and regenerative medicine.
71 ther investigation of SCNT as a strategy for regenerative medicine.
72 ntial implications for stem cell biology and regenerative medicine.
73 ationale of using appropriate stem cells for regenerative medicine.
74 l for the advancement of transplantation and regenerative medicine.
75 d for the development of novel strategies in regenerative medicine.
76 creting cells, achieving an elusive goal for regenerative medicine.
77 n of adult cells is a promising approach for regenerative medicine.
78 t agonists for translational applications in regenerative medicine.
79 erial scaffolds, which are indispensable for regenerative medicine.
80 ews that encompass the discipline of hepatic regenerative medicine.
81 oductive health, fertility preservation, and regenerative medicine.
82 o maintain the quality of cells intended for regenerative medicine.
83 eart disease and inform future strategies in regenerative medicine.
84 esident progenitors with great potential for regenerative medicine.
85 ents a generalizable platform technology for regenerative medicine.
86 an developmental studies, drug discovery and regenerative medicine.
87 oreactive immune cells may also be useful in regenerative medicine.
88 lopment, disease modeling, gene therapy, and regenerative medicine.
89 used biomaterials for tissue engineering and regenerative medicine.
90 serves to advance developmental research and regenerative medicine.
91 ility in the areas of tissue engineering and regenerative medicine.
92 cipline to facilitate stem cell research and regenerative medicine.
93 y, immunology, and embryonic stem cell-based regenerative medicine.
94 l applications for both disease modeling and regenerative medicine.
95 o differentiation and future applications in regenerative medicine.
96 ventricular noncompaction cardiomyopathy and regenerative medicine.
97 could open new opportunities in the field of regenerative medicine.
98 region-restricted adult tissue stem cells in regenerative medicine.
99 for their widespread distribution and use in regenerative medicine.
100 or tissue engineering, disease modeling, and regenerative medicine.
101 in many areas, such as biomedical devices or regenerative medicine.
102 xt generation of researchers in the field of regenerative medicine.
103 the potential therapeutic role of hypoxia in regenerative medicine.
104 otent stem cells (hPSCs) is a major goal for regenerative medicine.
105 l therapy represents a promising strategy in regenerative medicine.
106 egenerate should provide important clues for regenerative medicine.
107 cessary prior to use in drug development and regenerative medicine.
108 ls for drug screening, disease modeling, and regenerative medicine.
109 proteins in the context of drug delivery and regenerative medicine.
110 ar biomaterials are promising candidates for regenerative medicine.
111 s remains a concern for disease modeling and regenerative medicine.
112 ages for autologous, cell-based therapies in regenerative medicine.
113 portunities for studying development and for regenerative medicine.
114 mplex tissues has the potential to transform regenerative medicine.
115 niche, which may have major applications in regenerative medicine.
116 ls (PSC) have the potential to revolutionize regenerative medicine.
117 ore find application in cancer treatment and regenerative medicine.
118 ate macrophage phenotype as a useful tool in regenerative medicine.
119 lize human pluripotent stem cells (hPSCs) in regenerative medicine.
120 cell niches are modulated provides clues for regenerative medicine.
121 cytes for use in cardiovascular research and regenerative medicine.
122 cations of these findings for anticancer and regenerative medicine agendas dependent upon chemical in
125 netic resonance imaging (MRI) is crucial for regenerative medicine, allowing verification that the tr
127 luding cell therapy, tissue engineering, and regenerative medicine and are frequently used in preclin
131 have become a standard platform not only for regenerative medicine and developmental biology but also
135 ently produce cardiovascular progenitors for regenerative medicine and drug discovery applications.
137 these cells are considered to be useful for regenerative medicine and drug screening for liver disea
147 investigation of the roles of stem cells in regenerative medicine and pathogenesis of various diseas
148 rovide powerful resources for application in regenerative medicine and pharmaceutical development.
149 particular emphasis on diseases amenable to regenerative medicine and strategies to deal with barrie
150 tion of active agents, supports for cells in regenerative medicine and tissue engineering, biosensing
152 l applications including tissue engineering, regenerative medicine, and cell and therapeutic delivery
153 elial cell-seeding densities are required in regenerative medicine, and existing techniques are inade
155 anipulating YAP1 biology in cancer settings, regenerative medicine, and possibly also noncancer human
156 e for the development of novel approaches in regenerative medicine, and provides a unique tool for di
157 tive implications for developmental biology, regenerative medicine, and synthetic bioengineering.
159 of cellular reprogramming techniques used in regenerative medicine, and within this context, envision
161 e potential to accelerate the development of regenerative medicine applications based on implantation
162 ted unprecedented potential for a variety of regenerative medicine applications including novel drug
163 t stem cells may also open new frontiers for regenerative medicine applications, including the possib
174 useful in cancer prevention, treatment, and regenerative medicine applications; currently, a few com
180 ent efforts in cellular disease modeling and regenerative medicine are limited by the paucity of cell
182 terial microarrays hold enormous promise for regenerative medicine because of their ability to accele
183 s that have recently emerged as key tools in regenerative medicine because some of them can function
184 t interest in many different fields, such as regenerative medicine, biorobotics, and biosensing.
185 ia decellularization are a key instrument in regenerative medicine both per se and to drive the devel
186 ibroblasts holds potential as a strategy for regenerative medicine but until now has only been shown
187 an pluripotent stem cells hold potential for regenerative medicine, but available cell types have sig
188 ly relevant cells in vitro holds promise for regenerative medicine, but most protocols fail to faithf
189 l research has yielded promising advances in regenerative medicine, but standard assays generally lac
190 al for applications ranging from vaccines to regenerative medicine, but their design is often hindere
191 proposed as a source of replacement cells in regenerative medicine, but their plasticity and unlimite
192 ent stem (iPS) cells have great potential in regenerative medicine, but this depends on the integrity
194 lay a pivotal role in tissue engineering and regenerative medicine by functioning as biomimetic subst
195 folds have shown promise for applications in regenerative medicine by providing a natural extracellul
196 that in vivo reprogramming may revolutionize regenerative medicine by using a patient's own internal
198 ions in the fields of assisted reproduction, regenerative medicine, cancer, metabolic disorders and a
199 biomaterials for future in vitro studies of regenerative medicine, cell biology, as well as human de
203 se of human embryonic stem cells (hESCs) for regenerative medicine currently faces several hurdles, i
204 l cardiomyocytes has provided a platform for regenerative medicine, development, tissue engineering,
205 e great potential as a human model system in regenerative medicine, disease modeling, and drug screen
206 elf-assembled nanofibers for applications in regenerative medicine, drug delivery, and catalysis, amo
207 s logistical limitations on transplantation, regenerative medicine, drug discovery, and a variety of
208 be used for various applications, including regenerative medicine, drug sensitivity testing, gene ex
209 fined transcription factors has provided the regenerative medicine field with a new tool for cell rep
211 unced strategic partnerships with a specific regenerative medicine focus, signifying the growth and w
212 opment partnership landscape in the field of regenerative medicine, focusing on agreements involving
213 broad applications in tissue engineering and regenerative medicine, followed by a summary and perspec
214 of importance to the development of improved regenerative medicine for patients with white matter dis
215 ogels have emerged as promising scaffolds in regenerative medicine for the delivery of biomolecules t
216 ntinues to be made in the field of stem cell regenerative medicine for the treatment of cardiovascula
217 may offer a potential therapeutic target in regenerative medicine for the treatment of corneal endot
219 m adult tissues offer tangible potential for regenerative medicine, given their feasibility for autol
221 studies of human infectious disease, cancer, regenerative medicine, graft-versus-host disease, allerg
222 ation, remain limited and the possibility of regenerative medicine has lacked empirical support.
228 e into many cell types and are important for regenerative medicine; however, further work is needed t
229 m cell (MSC) therapy is an emerging field of regenerative medicine; however, it is often unclear how
230 ear transfer (SCNT) holds great potential in regenerative medicine; however, its applicability has be
237 estigations aiming at the manufacturing of a regenerative medicine-inspired bioartificial endocrine p
238 Stem cell tracking in cellular therapy and regenerative medicine is an urgent need, superparamagnet
245 A goal for periodontal tissue engineering/regenerative medicine is to restore oral soft and hard t
246 cells (MSCs) are a promising cell source for regenerative medicine, ischemia-induced endoplasmic reti
247 thin this context, envision how the scope of regenerative medicine may be expanded to treat metastati
248 t) unknown challenges, pursuit of myocardial regenerative medicine mediated by adult stem cell therap
249 tent stem cells (hPSCs) have applications in regenerative medicine, modeling of lung disease, drug sc
250 red to elicit targeted cellular responses in regenerative medicine must display bioligands with preci
252 lls, thus addressing a critical challenge in regenerative medicine of achieving cell-free scaffold-ba
253 otent stem cells (embryonic and induced) for regenerative medicine of incurable diseases, immunothera
254 al transplantation hold valuable lessons for regenerative medicine, offering approaches for developin
255 d their potential therapeutic application in regenerative medicine or angiogenesis-related diseases i
256 pluripotent stem cells are a cornerstone of regenerative medicine owing to their ability to give ris
257 rol, and demonstrate the potential to impact regenerative medicine, pharmacology and electronic thera
258 for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) have similar obje
259 atures have established NDs as an invaluable regenerative medicine platform, with a broad range of cl
260 terials developed for tissue engineering and regenerative medicine present tractable biomimetic syste
267 ammed human neurons for disease modeling and regenerative medicine relies on the ability to induce pa
269 PSC)-derived neurons in disease modeling and regenerative medicine requires analysis in complex funct
271 oised to revolutionize stem cell biology and regenerative medicine research, bringing unprecedented o
272 verse potential applications in research and regenerative medicine, so a readily available source cou
273 itions might facilitate the establishment of regenerative medicine strategies and enhance the transla
275 ey development, modeling disease, evaluating regenerative medicine strategies, as well as for toxicol
277 Application of seed-and-soil concepts to regenerative medicine strengthens prospects for developi
278 d induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced unde
279 m cells (hPSCs) provide valuable sources for regenerative medicine, their applicability is dependent
281 , gene therapy, drug screening, and emerging regenerative medicine therapies are fundamentally relian
282 dblocks to using stem cells as the basis for regenerative medicine therapies is the tumorigenicity of
283 f the field several decades ago, a number of regenerative medicine therapies, including those designe
284 ed pluripotent stem cell biology to clinical regenerative medicine therapies, new strategies to contr
291 tors differentiate into MSNs is critical for regenerative medicine to develop specific differentiatio
292 n mimics could have a crucial role in modern regenerative medicine to improve the storage and distrib
293 c stem/progenitor cells (hCPCs) may serve in regenerative medicine to repair the infarcted heart.
294 presents a promising approach to realizing a regenerative medicine treatment for craniofacial deforma
295 ults are a long-sought step for the field of regenerative medicine; until now, histology and scanning
296 dical devices lies at the confluence between regenerative medicine, where materials remodel and integ
298 on the paradigm of in vivo reprogramming for regenerative medicine, while pointing to hurdles that mu
299 We envisage that successful treatments in regenerative medicine will involve different combination
300 e engineering have enhanced the potential of regenerative medicine, yet the efficacy of these strateg
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。